These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1908617)

  • 21. In vivo assessment of an animal model of diabetic cataract: medical intervention studies.
    Joon TL; Foo K; Panagiotopoulos S; Jerums G; Taylor HR
    Dev Ophthalmol; 1994; 26():57-62. PubMed ID: 7895883
    [No Abstract]   [Full Text] [Related]  

  • 22. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does aldose reductase have a role in the development of the ocular complications of diabetes?
    Lightman S
    Eye (Lond); 1993; 7 ( Pt 2)():238-41. PubMed ID: 7607342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
    Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
    Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition in rat of development of in utero galactose-induced cataract by an aldose reductase inhibitor--a light microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1991; 35(3):317-24. PubMed ID: 1770672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG; Fathallah L
    Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of an aldose reductase inhibitor on altered sympathetic nerve responsiveness of isolated right atria in diabetic rats.
    Sato N; Hashimoto H; Takiguchi Y; Nakashima M
    Arzneimittelforschung; 1990 Jul; 40(7):763-6. PubMed ID: 2121149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 30. Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity.
    Badawy D; El-Bassossy HM; Fahmy A; Azhar A
    Can J Physiol Pharmacol; 2013 Feb; 91(2):101-7. PubMed ID: 23458193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats.
    Kumar MP; Sankeshi V; Naik RR; Thirupathi P; Das B; Raju TN
    Chem Biol Interact; 2015 Jul; 237():18-24. PubMed ID: 25986969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reinvestigation of streptozotocin induced diabetic cataract as a standard experimental model].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):324-32. PubMed ID: 8317349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of vanadium against diabetic cataracts in diabetic rat model.
    Sun L; Shi DJ; Gao XC; Mi SY; Yu Y; Han Q
    Biol Trace Elem Res; 2014 May; 158(2):219-23. PubMed ID: 24604151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.
    Suryanarayana P; Kumar PA; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2004 Mar; 10():148-54. PubMed ID: 15031705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on the variation of relaxation time in diabetic cataractous lenses of rats by using NMRA].
    Zhang Y; Zhang S; Hu X; Liu Q; Bai F; Zhang M
    Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):128-30. PubMed ID: 2167872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 38. Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats.
    Shimoshige Y; Minoura K; Matsuoka N; Takakura S; Mutoh S; Kamijo M
    Brain Res; 2009 Jan; 1247():182-7. PubMed ID: 18992730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.